Captor Therapeutics Spolka Akcyjna
CTX.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 223,360 | PLN 185,928 | PLN 214,327 | PLN 232,463 |
| - Cash | PLN 3,927 | PLN 15,196 | PLN 16,624 | PLN 39,257 |
| + Debt | PLN 3,818 | PLN 1,449 | PLN 4,688 | PLN 5,637 |
| Enterprise Value | PLN 223,251 | PLN 172,181 | PLN 202,391 | PLN 198,843 |
| Revenue | PLN 0 | PLN 2,010 | PLN 2,606 | PLN 2,954 |
| % Growth | -100% | -22.9% | -11.8% | – |
| Gross Profit | PLN 2,021 | -PLN 583 | PLN 1,733 | PLN 807 |
| % Margin | – | -29% | 66.5% | 27.3% |
| EBITDA | -PLN 10,416 | -PLN 9,432 | -PLN 9,390 | -PLN 7,512 |
| % Margin | – | -469.3% | -360.3% | -254.3% |
| Net Income | -PLN 11,477 | -PLN 9,755 | -PLN 10,719 | -PLN 8,760 |
| % Margin | – | -485.3% | -411.3% | -296.5% |
| EPS Diluted | -2.08 | -1.77 | -1.95 | -1.59 |
| % Growth | -17.5% | 9.2% | -22.6% | – |
| Operating Cash Flow | -PLN 11,511 | -PLN 10,597 | PLN 23,061 | -PLN 8,426 |
| Capital Expenditures | PLN 0 | PLN 1 | -PLN 83 | -PLN 424 |
| Free Cash Flow | -PLN 11,511 | -PLN 10,596 | PLN 22,978 | -PLN 8,850 |